15 results for "Perika (St. John's Wort)" between $5.00 and $25.00

Product Description Hyperforin: The Proved "Mood Enhancing" Active in St. John's Wort. New clinical research reveals hyperforin-rich Perika to be more effective in promoting positive mood than low hyperforin St. John's Wort. Perika's HyperiSure Difference Hyperforin is rather unstable and can lose potency over time. However, using the patented HyperiSure System technology, Perika contains a guaranteed level of hyperforin to deliver clinically proven effectiveness. Perika is scientifically advanced...

Perika is scientifically advanced to maintain a healthy emotional outlook Clinically proven Patented extract A patented St. John's Wort that is scientifically advanced to maintain a healthy emotional outlook. Nature's Way Perika is made by the Dr. Willmar Schwabe Company, a world leader in plant-based pharmaceutical research for over 100 years.

Perika St. John's Wort. Latin Name: Hypericum perforatum. Perika is the most scientifically advanced St. John's Wort extract on the market. The subject of breakthrough research, the patented Perika extract is the first to contain an effective amount of hyperforin, the newly discovered active ingredient responsible for mood enhancing effectiveness of St. John's Wort. (German patent &_hash_;DE 19619512C1, U.S. patent pending). When you're challenged by the disappointments, changing circumstances and...

Suggested Use: As a herbal dietary supplement for adults, one (1) to two (2) Vegicaps® daily, preferably at mealtime, or as directed by a healthcare practitioner. Serving Size 1 Vegicaps® Amount Per Vegicaps® Ingredients: Standardized St. John’s Wort Extract\ (aerial) (hypericin 1 mg [0.3%]) 300 mg (**) Raw St. John’s Wort Powder (aerial) 100 mg (**)

(Hypericum perforatum) is an herbal extract that has been used in European clinics for years. This material has been standardized to contain 0.3% Hypericin, one of the known active components that are contained in the herb.

Since the active components of hypericum do not seem able to pass the blood-brain barrier, it is hypothesized that their primary site of action must lie outside the central nervous system, and that effects could be brought about by mediators capable of passing into cerebrospinal fluid. Thiele, Brink, and Ploch feel that actions on cells of the immune system, such as lymphocytes and monocytes, would be likely. They discuss modulation of cytokine expression and secondary activating effects on CRH ...